New Antiarrhythmic Drugs for Atrial Fibrillation -- Dronedarone (Multaq) and Vernakalant, – Video
At the Boston Atrial Fibrillation Symposium 2010, Professor John Camm talked about the two newest antiarrhythmic drugs for atrial fibrillation treatment, dronedarone (Multaq®) and vernakalant. These antiarrhythmic (rhythm control) drugs help to put patients back into normal sinus rhythm, or to keep them in it.
See the video: Interview with Professor John Camm at Boston Atrial Fibrillation Symposium 2010
We value and respect the experiences of all of our HERWriters, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice although we hope you can gain knowledge from their insight.
Add a CommentComments
There are no comments yet. Be the first one and get the conversation started!